Mercado mundial de secuenciación de ADN y secuenciación de próxima generación: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

El mercado de la secuenciación de ADN y la secuenciación de próxima generación se beneficiará de mejores escenarios regulatorios y de reembolso para las pruebas diagnósticas basadas en la secuenciación de próxima generación. Las condiciones de financiación favorables en todo el mundo para la investigación genómica brindarán perspectivas de expansión atractivas. La expansión del mercado se acelera con el desarrollo de servicios y productos de secuenciación de próxima generación rentables para los investigadores.

Data Bridge Market Research analiza que el mercado de secuenciación de ADN y secuenciación de próxima generación, que fue de USD 13,82 mil millones en 2021, se disparará hasta USD 50,04 mil millones para 2029, y se espera que experimente una CAGR del 17,45% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Market Definition

High-throughput sequencing is another name for next-generation sequencing. NGS allows for fast base pair sequencing of DNA samples. NGS is advancing drug development and paving the way for future personalized medicine, genetic illnesses, and clinical diagnostics. Furthermore, next-generation sequencing (NGS) is a massively parallel sequencing method capable of determining the order of nucleotides in a full genome with scalability, ultra-high throughput, and rapid speed.

DNA Sequencing and Next-Generation Sequencing Market Dynamics

Drivers

• Increasing number of cancer cases

The increasing number of cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next generation sequencing and technological advancements in sequencing technologies, are all contributing to the growth of the DNA next generation sequencing market. The lack of experienced specialists, on the other hand, is likely to have a significant impact on the overall growth of the DNA next generation sequencing industry.

• Rising R&D activities for developing novel next generation sequencing technologies

Over the forecast period, the need for next-generation sequencing methods will grow as R&D activities for treatments used in the treatment of genetic disorders increase. A substantial market demand will be created as R&D investments increase and the number of studies related to the treatment of genetic disorders among individuals grows. Governments in industrialised economies have implemented a number of programmes and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.

• Increasing advantages of next generation sequencing techniques

In 2020, the academic institutes and research centres end-use category accounted for 45 percent of the market. Hospitals choose next-generation sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, next-generation sequencing can be utilised to collect the most up-to-date data and identify transmission links in order to avoid infections across hospital settings, which will boost market revenue.

Opportunities

The modifications and automation of this technique increased sequencing data while also helping researchers to better manage time, allowing them to attain important milestones in the Human Genome Project. Sequence-based gene expression analysis is now a "digital" alternative to analogue techniques. Genome sequencing has improved to the point where it is now simple and accurate. In the near future, these technical improvements are projected to enhance the size of the DNA next generation sequencing industry.

Restraints/Challenges

However, lack of skilled professionals, and ethical and legal limitation associated with NGS are expected to restrict the market growth during the forecast period.

This DNA sequencing and next-generation sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the DNA sequencing and next-generation sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 impact on DNA Sequencing and Next-Generation Sequencing Market

The COVID-19 epidemic had a huge influence on the world as a whole, causing economic collapse and death. It has resulted in a worldwide pandemic that is extremely transmissible. With the advancement of technology, next-generation sequencing is becoming increasingly important in a variety of fields. From manufacturing PPE kits to inventing test kits to detect the virus and vaccines to prevent transmission, a number of pharmaceutical businesses and agencies have contributed to reducing the infection's impact. To combat the virus, businesses have strengthened their R&D and production workforce. Because of the increasing benefit of determining and finding the genetic sequence of a virus, which helps scientists to comprehend the virus's entire mutation, the overall influence on the next generation sequencing industry and market is expected to be beneficial. Hundreds of coronaviruses and SARS-CoV-2 genomes which were determined with NGS are publicly available for researchers to study the origin of COVID-19.

Recent Development

• In December 2020, Eurofins Genomics has released SARS-CoV-2 NGS services that are both cost-effective and optimised, allowing for entire viral genome sequencing.
• In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.

The DNA sequencing and next-generation sequencing market is segmented on the basis of product, type, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Instruments
• Consumables
• Services

Type

• Whole genome sequencing
• Exome sequencing
• Targeted sequencing
• Others

Application

• Research application
• Clinical application
• Others

Technology

• Sequencing by synthesis
• Ion semiconductor sequencing
• Others

End-user

• Academic institutes and research centers
• Hospitals and clinics
• Pharmaceutical and biotechnology companies
• Others

DNA Sequencing and Next-Generation Sequencing Market Regional Analysis/Insights

The DNA sequencing and next-generation sequencing market is analysed and market size insights and trends are provided by country, product, type, technology, application and end-user as referenced above.

The countries covered in the DNA sequencing and next-generation sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

América del Norte domina el mercado debido a la presencia de varios laboratorios clínicos que utilizan NGS para ofrecer servicios de pruebas genéticas, lo que impulsa el mercado regional.

Se espera que Asia-Pacífico sea el mercado regional de más rápido crecimiento entre 2022 y 2029. Se espera que la presencia de empresas locales, como BGI Genomics, y proveedores de servicios NGS como First BASE Laboratories Sdn Bhd, Macrogen Asia-Pacific Pte Ltd. y otros, impulsen el mercado.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.

Análisis del panorama competitivo y de la cuota de mercado de la secuenciación de ADN y la secuenciación de próxima generación

El panorama competitivo del mercado de secuenciación de ADN y secuenciación de próxima generación proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de secuenciación de ADN y secuenciación de próxima generación.

Algunos de los principales actores que operan en el mercado de secuenciación de ADN y secuenciación de próxima generación son:

• Illumina Inc. (Estados Unidos)
• Thermo Fischer Scientific Inc. (Estados Unidos)
• Oxford Nanopore Technologies plc (Reino Unido)
• Agilent Technologies, Inc. (Estados Unidos)
• BGI (China)
• PerkinElmer Inc. (Estados Unidos)
• QIAGEN (Alemania)
• Eurofins Scientific (Luxemburgo)
• F. Hoffmann-La Roche Ltd (Suiza)
• Takara Bio Inc. (Japón)
• GENEWIZ, Inc. (Estados Unidos)
• Compañía Hamilton (Estados Unidos)
• Macrogen Inc. (Corea del Sur)
• Corporación de investigación Zymo (Estados Unidos)
• Tecan Trading AG (Suiza) 

SKU-54059